Larson Financial Group’s iBio IBIO Stock Holding History

Larson Financial Group’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3	Closed	-$2K	–	713
2020 Q1	$2K	Buy	+3	New	+$1.16K	﹤0.01%	435

Other funds holding IBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Larson Financial Group's IBIO Position: Q2 2020 in Review

Larson Financial Group sold out of iBio (IBIO) in Q2 2020, closing a stake of 3 shares — an estimated $2K sold.

Larson Financial Group first reported a position in IBIO in Q1 2020 and held it in 1 quarter. The position peaked at $2K in Q1 2020. 57 funds tracked by Wall St. Rank hold IBIO as of Q2 2020.

Larson Financial Group reported no remaining iBio position as of Q2 2020 after selling out during the quarter.
Larson Financial Group sold 3 iBio shares in Q2 2020, an estimated $2K.
Larson Financial Group first reported a position in iBio in Q1 2020 and held it in 1 quarter.
Larson Financial Group's iBio position peaked at $2K in Q1 2020.
57 funds tracked by Wall St. Rank held iBio as of Q2 2020.

Based on Larson Financial Group's 13F filing for Q2 2020, filed 10 Jul 2020.